C O N T E N T S Can the development of psoriatic arthritis be prevented in patients with psoriasis?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250 Nasonov E.L., Korotaeva T.V., Lila A.M., Kubanov A.A. I N T E R N A T I O N A L A N D R U S S I A N G U I D E L I N E S F O R T H E T R E A T M E N T O F R H E U M A T I C D I S E A S E S E D I T O R I A L Monitoring patients with systemic lupus erythematosus: general characteristics and discussion questions (according to the Canadian Rheumatology Association recommendations). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
255 Panafidina T.A., Popkova T.V., Solovyev S.K. O R I G I N A L I N V E S T I G A T I O N S Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation . . . . . 265 Ananyeva L.P., Koneva O.A., Desinova O.V., Garzanova L.A., Glukhova S.I., Starovoitova M.N., Ovsyannikova O.B., Volkov A.V., Aleksankin A.P., Nasonov E.L. Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis) . . . . . . . . . . . . . . . .
274 Avdeeva A.S., Satybaldyev A.M., Demidova N.V., Nikishina N.Yu., Gerasimova E.V., Muravyeva N.V., Gridneva G.I., Rumyantseva O.A., Kasumova K.A., Alekseeva A.V., Chichasova N.V., Kusevich D.A., Rybakova V.V., Koshkarova E.A., Lila A.M., Nasonov E.L. Insulin resistance in rheumatoid arthritis: relationship to lipid metabolism disorders and metabolic syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280 Kondratyeva L.V., Popkova T.V., Nasonov E.L. Possibilities of using a FRAX ® risk calculator for 10-year probability of fractures assessment in patients with rheumatoid arthritis . . . . . . . . . . . . . . 284 Nikitinskaya O.A., Toroptsova N.V., Nasonov E.L.
Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part II. Neonatal outcomes . . . . . . . . . . . . . . . . . . . . 289 Matyanova E.V., Kosheleva N.M., Kostareva O.M., Fedorova E.V., Klimenchenko N.I. Validation of the Russian-language version of the ASAS Health Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 294 Akulova A.I., Rebrov A.P., Erdes Sh., Gaydukova I.Z. The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice . . . . . . . . . . . . . . . . . . . . . .
299 Loginova E.Yu., Korsakova Yu.L., Koltakova A.D., Gubar E.E., Karpova P.L., Glukhova S.I., Korotaeva T.V. Time course of changes in the clinical and instrumental manifestations of coxitis in patients with ankylosing spondylitis during golimumab therapy: a GO-COX study. Preliminary results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307 Erdes Sh., Dubinina T.V., Agafonova E.M., Rumyantseva D.G., Davidyan S.Yu., Zemerova E.V., Kulikov A.I., Markova O.G. Effect of golimumab on endothelial vasomotor function and arterial stiffness in ankylosing spondylitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
312 Knyazeva L.A., Damjanov N., Knyazeva L.I., Meshcherina N.S., Goryainov I.I., Stepchenko M.A., Bobyntsev Ya.I., Rudakov O.S. P R O G R E S S I N R H E U M A T O L O G Y I N T H E 2 1 S T C E N T U R Y Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders . . . . . 318 Lisitsyna T.A., Veltishchev D.Yu., Lila A.M., Nasonov E.L. R E V I E W S Study of local and generalized bone loss in patients with rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328 Dydykina I.S., Kozhevnikova P.O.
Role of biomarkers in the diagnosis of bacterial infections in rheumatic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 333 Belov B.S., Tarasova G.M., Muravyeva N.V. P E D I A T R I C R H E U M A T O L O G Y Familial Mediterranean fever in the Republic of Crimea: a description of a series of cases with an analysis of historical and ethnographic aspects of the disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 339 Zhogova O.V., Lagunova N.V., Ivanovsky S.V., Salugina S.O., Kostik M.M.
O R T H O P E D I C R H E U M A T O L O G Y A N D R E H A B I L I T A T I O N Efficiency of local hyaluronic acid injections in subacromial impingement syndrome. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 345 Nesterenko V.A., Karateev A.E., Byalik E.I., Makarov M.A., Makarov S.A., Byalik V.E., Nurmukhametov M.R., Fedotov I.A. C L I N I C A L O B S E R V A T I O N Rheumatoid nodules in the lung parenchyma in rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 349 Satybaldyev A.M., Ananyeva L.P.
D I S C U S S I O N On the terms «rheumatology» and «rheumatic diseases» (regarding Sh. Erdes's article «Definition of the term “rheumatology”: do we need this and how do the EULAR and the ACR look at this?») . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 356 Muravyev Yu.V., Muravyeva L.A. I N F O R M A T I O N Minutes No. 22 of the Meeting of the Expert Council Task Force on Rheumatology Specialty, Ministry of Health of Russia on March 23, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
358 All-Russian Congress with international participation « Problems of autoimmunity and autoinflammation in rheumatology» Moscow, May 30 – June 1, 2019. Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363